×

Healthcare

USD Analytics healthcare data solutions deliver information, analytics, and solutions for the world’s major medical device, pharmaceutical companies, financial markets, and governments. The company leverages its vast databases and industry expertise to present in-depth and up-to-date analyses of healthcare industries. The solution enables users to make efficient and informed decisions across the market. The Global Healthcare markets service presents an analysis of 60 countries with an updated outlook for the pharmaceutical industry. The reports in the service are updated every month and present healthcare expenditure, pharmaceutical sales, pharmaceutical goods trade balance, population forecasts, life expectancy, Consumer Price Inflation, GDP forecast, regulatory analysis, and company profiles. The Pipeline, Epidemiology, and Disease Market Outlook service presents disease pipeline reviews, clinical trial analysis, epidemiology reports, and disease market outlook for over 300 conditions. In addition, Analysis of marketed drugs, upcoming drug candidates, and other information is included in the research solutions. Further, the market size outlook and competitive analysis of medical devices, Healthcare IT, Analytics and Instrumentation, and the Biotechnology industry outlook are analyzed.

Healthcare
Report Name

Life Science Analytics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics), By Component (Services, Software), By Delivery Model (On-premise model, On-demand model), By Application (Research & Development, Preclinical Trials, Clinical Trials, Sales & Marketing, Regulatory Compliance, Supply Chain Optimization, Pharmacovigilance), By End-User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers, Third-party Administrators), Countries and Companies Report

Life Science Analytics is projected to register a 9.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD0004016  |   No. of Pages: 205

OTC Vitamins and Minerals Dietary Supplements Market Insights, 2023- Forecasts and Opportunities by Type (Vitamins, Minerals, Other Dietary Supplements), Applications (Bone and Joint Health, Cardiac Health, Immunity Boosting & General Health, Gastrointestinal, Weight management & Energy, Others), Companies and Countries to 2030

OTC Vitamins and Minerals Dietary Supplements Market is estimated to grow at CAGR 8.2% during the forecast period 2023-2030. Geographically, the global market is divided into five major regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Published On: November, 2024  |   Report Code: USD00074  |   No. of Pages: 180

Healthcare CRM Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Component (Software, Solutions), By Functionality (Customer Service and Support, Digital Commerce, Marketing, Sales, Cross -CRM), By Deployment Mode (On-premise Model, Cloud/Web-based Model), By End-User (Healthcare Providers, Healthcare Payers, Life Sciences Industry), Countries and Companies Report

Global Healthcare CRM Market is forecast to register a CAGR of 12.1% from 18.8 Billion in 2024 to $37.3 Billion in 2030 driven by new product launches by companies

Published On: November, 2024  |   Report Code: USD0003934  |   No. of Pages: 195

Ultrasound Transducer Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Linear, Convex, Phased array, Endocavitary, CW Doppler, Others), By Application (Cardiovascular, General Imaging, Musculoskeletal, OB/GYN, Vascular, Others), By End-user (Hospital, Clinics, Diagnostic center, Ambulatory Surgery Centers), Countries and Companies Report

Ultrasound Transducer Market is projected to register a 3.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD0003594  |   No. of Pages: 208

Biopharmaceutical CMO And CRO Market Size, Share, Trends, Growth Outlook and Opportunities to 2030-by Source (Mammalian, Non-mammalian), by Service (Contract Manufacturing, Contract Research), by Product (Monoclonal antibodies (MAbs), Recombinant Proteins, Vaccines, Antisense, RNAi, & Molecular Therapy, Biosimilars, Others), and Companies Report

Biopharmaceutical CMO And CRO Market is projected to reach at a 6.5 CAGR during the period of 2023-2030. Geographically, the market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Published On: November, 2024  |   Report Code: USD0003310  |   No. of Pages: 180

Wearable Artificial Kidney Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Patient Type (End Stage Renal Disease, Acute Kidney Disease), By Dialysis (Haemodialysis, Peritoneal Dialysis), By End-user (Hospitals, Ambulatory Surgical Centers, Dialysis Centers, Others), Countries and Companies Report

Wearable Artificial Kidney Market is projected to register a 18.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD0001051  |   No. of Pages: 185

Veterinary Vaccines Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Others), By Disease (Porcine Diseases, Poultry Diseases, Livestock Diseases, Companion Animal Diseases, Aquaculture Diseases), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), By Route of Administration (Injection Vaccines, Oral Vaccines, Intranasal/Spray Vaccines), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Others), Countries and Companies Report

Veterinary Vaccines is projected to register a 6.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD0007416  |   No. of Pages: 205

Biobanks Market Outlook, 2023- Forecasts and Opportunities in the Biobanks Industry by Type (Bio Fluids, Human Tissues, Tumor Cells, Stem Cells, DNA/RNA, Others), Application (Therapeutics, Diagnostics, Research), Product (Consumables, Equipment), Companies and Countries to 2030

Biobanks market is projected to grow at a CAGR of 6.8% over the period of 2023-2030. Geographically, the global market is divided into five major regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

Published On: November, 2024  |   Report Code: USD00077  |   No. of Pages: 203

Digital Biomarkers Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Wearable, Mobile based Applications, Sensors, Others), By Clinical Practice (Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive and Prognostic Digital Biomarkers, Others), By Therapeutic Area (Cardiovascular and metabolic disorders (CVMD), Respiratory disorders, Psychiatric disorders, Sleep & Movement Disease, Neurological disorders, Musculoskeletal disorders, Others), By End-user (Healthcare companies, Healthcare Providers, Payers, Others), Countries and Companies Report

Digital Biomarkers Market is projected to register a 28.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD0003919  |   No. of Pages: 196

Chronic Kidney Disease Nutritional Supplement Market Size, Share, Trends, Growth Outlook and Opportunities to 2030- By Nutrition Type (Amino Acid Supplements, Vitamin & Mineral Supplements, Probiotics, Prebiotics / Fibers, And Others) By Dosage Form (Capsule, Liquid, Powder, And Others) By FSMP Mode Of Administration (Oral Nutrition (ON), And Enteral Nutrition (EN)) By CKD Stage (Pre-Dialysis Stage 1-2, Pre-Dialysis Stage 3-5, Dialysis, And End-Stage Renal Disease), And by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Stores), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Chronic Kidney Disease Nutritional Supplement Market is projected to reach at a high CAGR during the period of 2023-2030. Geographically, the market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Published On: November, 2024  |   Report Code: USD0007425  |   No. of Pages: 200

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us